To investigate the potential role of SNX1 in modulating chemosensitivity in ovarian cancer, drug response prediction analysis was performed for multiple chemotherapeutic agents, including 5-fluorouracil, docetaxel, paclitaxel, cisplatin, and oxaliplatin. The gene discussed is SNX1; the disease is ovarian carcinoma.